Literature DB >> 25313426

Laronidase hypersensitivity and desensitization in type I mucopolysaccharidosis: a case report.

Luis Felipe Ensina, Carolina Sanchez Aranda, Alex Eustaquio de Lacerda, Inês Camelo-Nunes, Dirceu Sole, Ana Maria Martins, Mariana Castells.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25313426     DOI： 10.1111/pai.12209

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN： 0905-6157            Impact factor:   6.377


× No keyword cloud information.
  4 in total

1.  Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome.

Authors:  Angela C Sosa; Barbara Kariuki; Qi Gan; Alan P Knutsen; Clifford J Bellone; Miguel A Guzmán; Luis A Barrera; Shunji Tomatsu; Anil K Chauhan; Eric Armbrecht; Adriana M Montaño
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 2.  Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations.

Authors:  Rossella Parini; Federica Deodato
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

Review 3.  Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management.

Authors:  Luis Felipe Ensina; Taek Ki Min; Mara Morelo Rocha Félix; Carolina Tavares de Alcântara; Célia Costa
Journal:  Front Allergy       Date:  2022-04-15

4.  Enzyme replacement therapy interruption in patients with Mucopolysaccharidoses: Recommendations for distinct scenarios in Latin America.

Authors:  MarthaL Solano; Alejandro Fainboim; Juan Politei; Gloria L Porras-Hurtado; Ana Maria Martins; Carolina F Moura Souza; Felipe Mendez Koch; Hernan Amartino; Jose Maria Satizábal; Dafne D G Horovitz; Paula F V Medeiros; Rachel S Honjo; Charles M Lourenço
Journal:  Mol Genet Metab Rep       Date:  2020-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.